METHYLENE BLUE INJECTION USP 10 MG
METHYLENE BLUE : 10 MG · DIN 00816108 · SANDOZ CANADA INCORPORATED
Health Canada status: CANCELLED POST MARKET
What is METHYLENE BLUE INJECTION USP?
METHYLENE BLUE INJECTION USP 10 MG contains METHYLENE BLUE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 00816108, held by SANDOZ CANADA INCORPORATED, supplied as SOLUTION for PARENTERAL (UNSPECIFIED) administration. Health Canada currently lists it as cancelled post market, status dated 01-Aug-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00816108 |
|---|---|
| Brand name | METHYLENE BLUE INJECTION USP |
| Generic / active ingredient | METHYLENE BLUE : 10 MG |
| Manufacturer | SANDOZ CANADA INCORPORATED |
| Strength | 10 MG |
| Dosage form | SOLUTION |
| Route of administration | PARENTERAL (UNSPECIFIED) |
| Schedule | Ethical |
| ATC code | V03AB17 METHYLTHIONINIUM CHLORIDE |
| AHFS class | 91:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 01-Aug-2019 |
| Original market date | 1989-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code V03AB17 METHYLTHIONINIUM CHLORIDE. 2 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| METHYLENE BLUE INJECTION | 10 MG | SOLUTION | PHEBRA PTY LTD | MARKETED | DIN 02487993 |
| METHYLENE BLUE INJECTION USP | 10 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02230770 |
| METHYLENE BLEU LIQ 2% | 2 % | LIQUID | LABORATOIRE ATLAS INC | CANCELLED POST MARKET | DIN 00050474 |
| METHYLENE BLUE INJ 1% | 10 MG | LIQUID | ALLEN & HANBURYS A GLAXO CANADA LTD. CO. | CANCELLED POST MARKET | DIN 00465062 |
| METHYLENE BLUE INJ 1% USP | 1 % | LIQUID | DAVID BULL LABORATORIES (PTY) LTD. | CANCELLED POST MARKET | DIN 00863610 |
| METHYLENE BLUE INJ 10MG/ML USP | 10 MG | LIQUID | GLAXO CANADA INC | CANCELLED POST MARKET | DIN 01958674 |
| METHYLENE BLUE INJECTION USP | 10 MG | SOLUTION | ALVEDA PHARMACEUTICALS INC | CANCELLED (UNRETURNED ANNUAL) | DIN 02302756 |
| METHYLENE BLUE INJECTION USP | 10 MG | SOLUTION | HIKMA CANADA LIMITED | CANCELLED POST MARKET | DIN 02431548 |
| METHYLENE BLUE INJECTION, USP | 1 % | LIQUID | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 02137194 |
| METHYLENE BLUE INJECTION, USP | 10 MG | SOLUTION | MYLAN PHARMACEUTICALS ULC | CANCELLED PRE MARKET | DIN 02094665 |
Who else supplies METHYLTHIONINIUM CHLORIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. METHYLTHIONINIUM CHLORIDE appears in 5 registered pack listings across 3 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.